Absci Corp ABSI

US Biotechnology

$9.74 ▼ -5.85% ($-0.61)

🔥 High Short Interest 🎢 High Beta

Open $10.49

Prev Close $10.35

Day Range $9.68 – $10.50

52W Range $2.24 – $12.06

Market Cap $1.67B

Beta 2.24

EPS (TTM) $-0.80

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-07-22
Shares Out.	168,850,000
Website	absci.com/ ↗
Phone	13026587581
Employees	140
Revenue	$318,000
Gross Profit	$318,000
Net Income	-$33.2M
Free Cash Flow	-$109.0M
Total Assets	$268.9M
Total Liabilities	$22.8M
Equity	$246.1M

About Absci Corp

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

Absci Corp is a publicly traded company under the ticker symbol ABSI on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.